Skip to content
    Inve.money
    Earnings calls

    Sai Parenterals Limited concall ledger

    Every earnings call for SAIPARENT — management tone, guidance, KPIs and promise tracking, quarter by quarter.

    SAIPARENT · 1 transcript · Healthcare · latest Q4 FY26

    Sai Parenterals Limited has 1 earnings call on record here, a Healthcare company, most recently Q4 FY26. Each quarter is scored on revenue, margins, guidance delivery and the questions management left unanswered — so the gap between what was promised and what was delivered is easy to read.

    Q4 FY26Published 27 May 2026Call held 27 May 2026

    SAIPARENT Q4 FY26 Earnings Call Transcript & Analysis

    Consolidated FY26 Revenue₹381 cr+133% YoYConsolidated FY26 EBITDA₹47 cr+18% YoYConsolidated Q4 FY26 Revenue₹198 crConsolidated Q4 FY26 EBITDA₹29 crConsolidated Q4 FY26 EBITDA Margin15%

    Consolidated FY26 Revenue ₹381 cr (+133% YoY); Consolidated FY26 EBITDA ₹47 cr (+18% YoY); Consolidated Q4 FY26 Revenue ₹198 cr. FY26 was a transformational year, including a successful public listing and the acquisition of Noumed Pharmaceuticals.

    Read full transcript & analysis